nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Tamoxifen—pancreatic cancer	0.0332	0.241	CbGbCtD
Dorzolamide—CYP2C9—Fluorouracil—pancreatic cancer	0.0245	0.177	CbGbCtD
Dorzolamide—CYP3A4—Tamoxifen—pancreatic cancer	0.0193	0.14	CbGbCtD
Dorzolamide—CYP3A4—Erlotinib—pancreatic cancer	0.0164	0.119	CbGbCtD
Dorzolamide—CYP3A4—Irinotecan—pancreatic cancer	0.0148	0.107	CbGbCtD
Dorzolamide—CYP3A4—Docetaxel—pancreatic cancer	0.0109	0.0787	CbGbCtD
Dorzolamide—CYP3A4—Sunitinib—pancreatic cancer	0.0108	0.0784	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—pancreatic cancer	0.0081	0.0587	CbGbCtD
Dorzolamide—CA9—gall bladder—pancreatic cancer	0.00561	0.19	CbGeAlD
Dorzolamide—CA9—islet of Langerhans—pancreatic cancer	0.00368	0.125	CbGeAlD
Dorzolamide—CA7—digestive system—pancreatic cancer	0.00251	0.0853	CbGeAlD
Dorzolamide—CA9—digestive system—pancreatic cancer	0.00221	0.0749	CbGeAlD
Dorzolamide—CA2—gall bladder—pancreatic cancer	0.00213	0.0723	CbGeAlD
Dorzolamide—CA5B—pancreas—pancreatic cancer	0.00172	0.0582	CbGeAlD
Dorzolamide—CA4—islet of Langerhans—pancreatic cancer	0.00168	0.0572	CbGeAlD
Dorzolamide—CA12—digestive system—pancreatic cancer	0.00163	0.0554	CbGeAlD
Dorzolamide—CA1—pancreas—pancreatic cancer	0.00151	0.0514	CbGeAlD
Dorzolamide—CA2—islet of Langerhans—pancreatic cancer	0.0014	0.0474	CbGeAlD
Dorzolamide—CA1—digestive system—pancreatic cancer	0.00129	0.0439	CbGeAlD
Dorzolamide—CA4—digestive system—pancreatic cancer	0.00101	0.0343	CbGeAlD
Dorzolamide—CA2—pancreas—pancreatic cancer	0.000982	0.0333	CbGeAlD
Dorzolamide—Pain in extremity—Doxorubicin—pancreatic cancer	0.000893	0.00107	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—pancreatic cancer	0.000893	0.00107	CcSEcCtD
Dorzolamide—Paraesthesia—Gemcitabine—pancreatic cancer	0.00089	0.00107	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000888	0.00107	CcSEcCtD
Dorzolamide—Asthenia—Sunitinib—pancreatic cancer	0.000887	0.00106	CcSEcCtD
Dorzolamide—Decreased appetite—Irinotecan—pancreatic cancer	0.000885	0.00106	CcSEcCtD
Dorzolamide—Arrhythmia—Docetaxel—pancreatic cancer	0.000885	0.00106	CcSEcCtD
Dorzolamide—Dyspnoea—Gemcitabine—pancreatic cancer	0.000884	0.00106	CcSEcCtD
Dorzolamide—Insomnia—Fluorouracil—pancreatic cancer	0.000882	0.00106	CcSEcCtD
Dorzolamide—Somnolence—Gemcitabine—pancreatic cancer	0.000881	0.00106	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—pancreatic cancer	0.000879	0.00106	CcSEcCtD
Dorzolamide—Fatigue—Irinotecan—pancreatic cancer	0.000878	0.00105	CcSEcCtD
Dorzolamide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000875	0.00105	CcSEcCtD
Dorzolamide—Alopecia—Docetaxel—pancreatic cancer	0.000875	0.00105	CcSEcCtD
Dorzolamide—Pruritus—Sunitinib—pancreatic cancer	0.000874	0.00105	CcSEcCtD
Dorzolamide—Pain—Irinotecan—pancreatic cancer	0.00087	0.00105	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00087	0.00104	CcSEcCtD
Dorzolamide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000869	0.00104	CcSEcCtD
Dorzolamide—Somnolence—Fluorouracil—pancreatic cancer	0.000867	0.00104	CcSEcCtD
Dorzolamide—Erythema—Docetaxel—pancreatic cancer	0.000862	0.00104	CcSEcCtD
Dorzolamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000862	0.00104	CcSEcCtD
Dorzolamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000858	0.00103	CcSEcCtD
Dorzolamide—Nausea—Tamoxifen—pancreatic cancer	0.000857	0.00103	CcSEcCtD
Dorzolamide—Fatigue—Gemcitabine—pancreatic cancer	0.000855	0.00103	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00085	0.00102	CcSEcCtD
Dorzolamide—Pain—Gemcitabine—pancreatic cancer	0.000848	0.00102	CcSEcCtD
Dorzolamide—Nausea—Erlotinib—pancreatic cancer	0.000848	0.00102	CcSEcCtD
Dorzolamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000847	0.00102	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—pancreatic cancer	0.000846	0.00102	CcSEcCtD
Dorzolamide—Diarrhoea—Sunitinib—pancreatic cancer	0.000845	0.00102	CcSEcCtD
Dorzolamide—Dysgeusia—Docetaxel—pancreatic cancer	0.000844	0.00101	CcSEcCtD
Dorzolamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000839	0.00101	CcSEcCtD
Dorzolamide—CA2—digestive system—pancreatic cancer	0.000838	0.0285	CbGeAlD
Dorzolamide—Influenza—Epirubicin—pancreatic cancer	0.000835	0.001	CcSEcCtD
Dorzolamide—Back pain—Docetaxel—pancreatic cancer	0.000834	0.001	CcSEcCtD
Dorzolamide—Pain—Fluorouracil—pancreatic cancer	0.000834	0.001	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000832	0.001	CcSEcCtD
Dorzolamide—Dizziness—Sunitinib—pancreatic cancer	0.000817	0.000982	CcSEcCtD
Dorzolamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000817	0.000981	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—pancreatic cancer	0.000813	0.000977	CcSEcCtD
Dorzolamide—Body temperature increased—Irinotecan—pancreatic cancer	0.000805	0.000967	CcSEcCtD
Dorzolamide—Abdominal pain—Irinotecan—pancreatic cancer	0.000805	0.000967	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000805	0.000966	CcSEcCtD
Dorzolamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000803	0.000965	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—pancreatic cancer	0.000803	0.000964	CcSEcCtD
Dorzolamide—Vomiting—Sunitinib—pancreatic cancer	0.000786	0.000944	CcSEcCtD
Dorzolamide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000784	0.000942	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—pancreatic cancer	0.00078	0.000937	CcSEcCtD
Dorzolamide—Rash—Sunitinib—pancreatic cancer	0.000779	0.000936	CcSEcCtD
Dorzolamide—Dermatitis—Sunitinib—pancreatic cancer	0.000778	0.000935	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000776	0.000932	CcSEcCtD
Dorzolamide—Urticaria—Fluorouracil—pancreatic cancer	0.000774	0.00093	CcSEcCtD
Dorzolamide—Headache—Sunitinib—pancreatic cancer	0.000774	0.00093	CcSEcCtD
Dorzolamide—Syncope—Docetaxel—pancreatic cancer	0.000773	0.000929	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—pancreatic cancer	0.000772	0.000928	CcSEcCtD
Dorzolamide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000771	0.000926	CcSEcCtD
Dorzolamide—Palpitations—Docetaxel—pancreatic cancer	0.000762	0.000915	CcSEcCtD
Dorzolamide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000758	0.00091	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—pancreatic cancer	0.000755	0.000907	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000753	0.000904	CcSEcCtD
Dorzolamide—Cough—Docetaxel—pancreatic cancer	0.000752	0.000904	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000752	0.000904	CcSEcCtD
Dorzolamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00075	0.000901	CcSEcCtD
Dorzolamide—Hypertension—Docetaxel—pancreatic cancer	0.000744	0.000894	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—pancreatic cancer	0.000743	0.000892	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000738	0.000886	CcSEcCtD
Dorzolamide—Chest pain—Docetaxel—pancreatic cancer	0.000734	0.000882	CcSEcCtD
Dorzolamide—Arthralgia—Docetaxel—pancreatic cancer	0.000734	0.000882	CcSEcCtD
Dorzolamide—Nausea—Sunitinib—pancreatic cancer	0.000734	0.000882	CcSEcCtD
Dorzolamide—Asthenia—Irinotecan—pancreatic cancer	0.00073	0.000877	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—pancreatic cancer	0.000723	0.000869	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—pancreatic cancer	0.000723	0.000869	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—pancreatic cancer	0.000722	0.000867	CcSEcCtD
Dorzolamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000718	0.000863	CcSEcCtD
Dorzolamide—Dry mouth—Docetaxel—pancreatic cancer	0.000718	0.000862	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000718	0.000862	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—pancreatic cancer	0.000713	0.000857	CcSEcCtD
Dorzolamide—Asthenia—Gemcitabine—pancreatic cancer	0.000711	0.000855	CcSEcCtD
Dorzolamide—Confusional state—Docetaxel—pancreatic cancer	0.000709	0.000852	CcSEcCtD
Dorzolamide—CYP2C9—digestive system—pancreatic cancer	0.000709	0.0241	CbGeAlD
Dorzolamide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000704	0.000845	CcSEcCtD
Dorzolamide—Oedema—Docetaxel—pancreatic cancer	0.000704	0.000845	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—pancreatic cancer	0.000702	0.000843	CcSEcCtD
Dorzolamide—Pruritus—Gemcitabine—pancreatic cancer	0.000702	0.000843	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—pancreatic cancer	0.000699	0.000839	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—pancreatic cancer	0.000698	0.000839	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000697	0.000837	CcSEcCtD
Dorzolamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000696	0.000837	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000694	0.000834	CcSEcCtD
Dorzolamide—Shock—Docetaxel—pancreatic cancer	0.000692	0.000832	CcSEcCtD
Dorzolamide—Pruritus—Fluorouracil—pancreatic cancer	0.00069	0.000829	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000683	0.00082	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—pancreatic cancer	0.00068	0.000817	CcSEcCtD
Dorzolamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000678	0.000815	CcSEcCtD
Dorzolamide—Dizziness—Irinotecan—pancreatic cancer	0.000673	0.000809	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—pancreatic cancer	0.000671	0.000806	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000669	0.000804	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000669	0.000804	CcSEcCtD
Dorzolamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000667	0.000801	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—pancreatic cancer	0.000663	0.000796	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—pancreatic cancer	0.00066	0.000793	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—pancreatic cancer	0.000658	0.00079	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—pancreatic cancer	0.000649	0.00078	CcSEcCtD
Dorzolamide—Vomiting—Irinotecan—pancreatic cancer	0.000647	0.000777	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—pancreatic cancer	0.000646	0.000776	CcSEcCtD
Dorzolamide—Dizziness—Fluorouracil—pancreatic cancer	0.000645	0.000774	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—pancreatic cancer	0.000644	0.000773	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000643	0.000772	CcSEcCtD
Dorzolamide—Rash—Irinotecan—pancreatic cancer	0.000642	0.000771	CcSEcCtD
Dorzolamide—Dermatitis—Irinotecan—pancreatic cancer	0.000641	0.00077	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000641	0.00077	CcSEcCtD
Dorzolamide—Headache—Irinotecan—pancreatic cancer	0.000638	0.000766	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—pancreatic cancer	0.000636	0.000764	CcSEcCtD
Dorzolamide—Paraesthesia—Docetaxel—pancreatic cancer	0.000632	0.000759	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000632	0.000759	CcSEcCtD
Dorzolamide—Vomiting—Gemcitabine—pancreatic cancer	0.00063	0.000757	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—pancreatic cancer	0.000629	0.000756	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—pancreatic cancer	0.000627	0.000754	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—pancreatic cancer	0.000626	0.000751	CcSEcCtD
Dorzolamide—Rash—Gemcitabine—pancreatic cancer	0.000625	0.000751	CcSEcCtD
Dorzolamide—Dermatitis—Gemcitabine—pancreatic cancer	0.000625	0.00075	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—pancreatic cancer	0.000623	0.000748	CcSEcCtD
Dorzolamide—Headache—Gemcitabine—pancreatic cancer	0.000621	0.000746	CcSEcCtD
Dorzolamide—Vomiting—Fluorouracil—pancreatic cancer	0.00062	0.000745	CcSEcCtD
Dorzolamide—Dyspepsia—Docetaxel—pancreatic cancer	0.000619	0.000744	CcSEcCtD
Dorzolamide—Rash—Fluorouracil—pancreatic cancer	0.000615	0.000738	CcSEcCtD
Dorzolamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000614	0.000738	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000613	0.000737	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000612	0.000735	CcSEcCtD
Dorzolamide—Headache—Fluorouracil—pancreatic cancer	0.000611	0.000734	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—pancreatic cancer	0.000607	0.000729	CcSEcCtD
Dorzolamide—Nausea—Irinotecan—pancreatic cancer	0.000605	0.000726	CcSEcCtD
Dorzolamide—Pain—Docetaxel—pancreatic cancer	0.000602	0.000723	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—pancreatic cancer	0.000597	0.000717	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—pancreatic cancer	0.000596	0.000716	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—pancreatic cancer	0.00059	0.000709	CcSEcCtD
Dorzolamide—Nausea—Gemcitabine—pancreatic cancer	0.000589	0.000707	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000584	0.000702	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—pancreatic cancer	0.000582	0.000699	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.00058	0.000697	CcSEcCtD
Dorzolamide—Nausea—Fluorouracil—pancreatic cancer	0.000579	0.000696	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—pancreatic cancer	0.000576	0.000692	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000575	0.000691	CcSEcCtD
Dorzolamide—Tension—Epirubicin—pancreatic cancer	0.000571	0.000685	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—pancreatic cancer	0.000569	0.000684	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—pancreatic cancer	0.000565	0.000678	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—pancreatic cancer	0.000563	0.000676	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—pancreatic cancer	0.000556	0.000668	CcSEcCtD
Dorzolamide—Body temperature increased—Docetaxel—pancreatic cancer	0.000556	0.000668	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000552	0.000663	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—pancreatic cancer	0.000548	0.000658	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—pancreatic cancer	0.000546	0.000656	CcSEcCtD
Dorzolamide—CYP3A4—digestive system—pancreatic cancer	0.000541	0.0184	CbGeAlD
Dorzolamide—Erythema—Doxorubicin—pancreatic cancer	0.000538	0.000646	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—pancreatic cancer	0.000528	0.000634	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000527	0.000633	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—pancreatic cancer	0.000523	0.000628	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—pancreatic cancer	0.000522	0.000628	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—pancreatic cancer	0.000522	0.000626	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—pancreatic cancer	0.00052	0.000625	CcSEcCtD
Dorzolamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000518	0.000623	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—pancreatic cancer	0.000514	0.000617	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000511	0.000614	CcSEcCtD
Dorzolamide—Cough—Epirubicin—pancreatic cancer	0.000507	0.00061	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—pancreatic cancer	0.000507	0.000609	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—pancreatic cancer	0.000505	0.000606	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—pancreatic cancer	0.000502	0.000603	CcSEcCtD
Dorzolamide—Pruritus—Docetaxel—pancreatic cancer	0.000498	0.000598	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—pancreatic cancer	0.000495	0.000595	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—pancreatic cancer	0.000495	0.000595	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—pancreatic cancer	0.000493	0.000593	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—pancreatic cancer	0.000489	0.000588	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—pancreatic cancer	0.000484	0.000582	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—pancreatic cancer	0.000483	0.000581	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—pancreatic cancer	0.000483	0.00058	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000481	0.000578	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—pancreatic cancer	0.000479	0.000575	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—pancreatic cancer	0.000476	0.000571	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000475	0.00057	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—pancreatic cancer	0.000475	0.00057	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000473	0.000568	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—pancreatic cancer	0.00047	0.000564	CcSEcCtD
Dorzolamide—Shock—Epirubicin—pancreatic cancer	0.000467	0.000561	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—pancreatic cancer	0.000465	0.000559	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—pancreatic cancer	0.000465	0.000558	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000459	0.000551	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—pancreatic cancer	0.000458	0.00055	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—pancreatic cancer	0.000458	0.00055	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—pancreatic cancer	0.000457	0.000548	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—pancreatic cancer	0.000453	0.000544	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—pancreatic cancer	0.000452	0.000543	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000448	0.000538	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—pancreatic cancer	0.000447	0.000537	CcSEcCtD
Dorzolamide—Rash—Docetaxel—pancreatic cancer	0.000444	0.000533	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—pancreatic cancer	0.000443	0.000533	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—pancreatic cancer	0.000443	0.000532	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—pancreatic cancer	0.000443	0.000532	CcSEcCtD
Dorzolamide—Headache—Docetaxel—pancreatic cancer	0.000441	0.00053	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000439	0.000528	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—pancreatic cancer	0.000439	0.000528	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000432	0.000519	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—pancreatic cancer	0.000432	0.000519	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—pancreatic cancer	0.000429	0.000516	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000426	0.000512	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000425	0.00051	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—pancreatic cancer	0.000423	0.000508	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—pancreatic cancer	0.000422	0.000507	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—pancreatic cancer	0.000419	0.000503	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—pancreatic cancer	0.000418	0.000502	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000418	0.000502	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000413	0.000496	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—pancreatic cancer	0.00041	0.000493	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—pancreatic cancer	0.000409	0.000492	CcSEcCtD
Dorzolamide—Pain—Epirubicin—pancreatic cancer	0.000406	0.000488	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.0004	0.000481	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—pancreatic cancer	0.000397	0.000477	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000394	0.000474	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000392	0.00047	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000391	0.00047	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—pancreatic cancer	0.00039	0.000469	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000388	0.000466	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000387	0.000464	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000382	0.000459	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—pancreatic cancer	0.000379	0.000455	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—pancreatic cancer	0.000377	0.000453	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—pancreatic cancer	0.000376	0.000451	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—pancreatic cancer	0.000375	0.000451	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—pancreatic cancer	0.000375	0.000451	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000362	0.000435	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000359	0.000431	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00035	0.00042	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—pancreatic cancer	0.000349	0.000419	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000347	0.000417	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000347	0.000417	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—pancreatic cancer	0.000341	0.000409	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—pancreatic cancer	0.000336	0.000403	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000325	0.00039	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000324	0.000389	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—pancreatic cancer	0.000315	0.000378	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—pancreatic cancer	0.000314	0.000377	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—pancreatic cancer	0.000311	0.000373	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—pancreatic cancer	0.000302	0.000362	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.0003	0.000361	CcSEcCtD
Dorzolamide—Rash—Epirubicin—pancreatic cancer	0.000299	0.000359	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—pancreatic cancer	0.000299	0.000359	CcSEcCtD
Dorzolamide—Headache—Epirubicin—pancreatic cancer	0.000297	0.000357	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—pancreatic cancer	0.00029	0.000349	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—pancreatic cancer	0.000282	0.000339	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—pancreatic cancer	0.000279	0.000335	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—pancreatic cancer	0.000277	0.000333	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000277	0.000332	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—pancreatic cancer	0.000275	0.00033	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—pancreatic cancer	0.000261	0.000313	CcSEcCtD
